Search Results 991-1000 of 18655 for hepatitis

  1. A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Cirrhosis- FALCON 1 Study - Mayo Clinic

    Other causes of liver disease (e.g., alcoholic liver disease, hepatitis B virus infection, chronic hepatitis C virus infection, autoimmune hepatitis, drug ...

  2. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    Active hepatitis B virus (HBV) or hepatitis C virus infection that requires treatment or at risk for HBV reactivation. At risk for HBV reactivation is ...

  3. Hemophilia - Diagnosis and treatment - Mayo Clinic

    People with hemophilia should receive recommended vaccinations at the appropriate ages, as well as hepatitis A and B. Requesting use of the smallest gauge ...

  4. Muscle pain When to see a doctor - Mayo Clinic

    Hepatitis C: What happens in end-stage liver disease? Herbal treatment for anxiety: Is it effective? High-dose flu vaccines: How are they different from other ...

  5. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid RNA [qualitative] ...

  6. A Study of Healthy Donor Volunteers to Provide Blood components Via Leukapheresis for In vitro Dendritic Cell Investigations - Mayo Clinic

    No history Hepatitis B or C seropositivity. No history Infectious or Idiopathic hepatitis or unexplained jaundice. Female subjects should not be pregnant ...

  7. Living Donor Organ Donation Archives - Mayo Clinic News Network

    ... hepatitis, are eligible to donate as well. More diverse donors are needed. Approximately 60% of people on the waitlist for a transplant are people of color ...

  8. Etanercept-ykro (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Alcoholic hepatitis, moderate to severe or; Blood or bone marrow problems (eg, aplastic anemia, low white blood cells), history of or; Congestive heart ...

  9. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    Active hepatitis B infection as demonstrated by test for hepatitis B surface antigen. Participants who are hepatitis B surface antigen negative but are ...

  10. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... hepatitis B surface antigen positivity, or hepatitis C with measurable viral titer. NOTE: Patients with antibody to hepatitis B core antibody are eligible ...